Misoprostol in obstetrics and gynecology

International Journal of Gynecology and Obstetrics

Volumn 99, Issue SUPPL. 2, 2007, Pages

  Weeks, A ^a   Faundes A ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; ERYTHROMYCIN; MAGNESIUM SULFATE; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN;

ABORTION; CESAREAN SECTION; CHORIOAMNIONITIS; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG PACKAGING; DRUG USE; ECLAMPSIA; EDITORIAL; FETUS DEATH; FOOD AND DRUG ADMINISTRATION; GYNECOLOGY; LABOR INDUCTION; MATERNAL MORTALITY; MISSED ABORTION; OBSTETRICS; PRESCRIPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REPRODUCTIVE HEALTH; RESPIRATORY DISTRESS SYNDROME; SINGLE DRUG DOSE; UTERUS CONTRACTION; WORLD HEALTH ORGANIZATION;

EID: 36048969792     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.09.003     Document Type: Editorial

References (42)

1. Clark S., Blum J., Blanchard K., Galvao L., Fletcher H., and Winikoff B. Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States. Int J Gynecol Obstet 76 (2002) 65-74
2. Fletcher H., and Hutchinson S. A retrospective review of pregnancy outcome after misoprostol (prostaglandin E1) induction of labour. West Indian Med J 50 1 (Mar 2001) 47-49
3. Hofmeyr G.J., and Gulmezoglu A.M. Vaginal misoprostol for cervical ripening and induction of labour (Cochrane Review). The Cochrane Library, Issue 2 (2002), Update Software, Oxford
4. Wagner M. Adverse events following misoprostol induction of labor. Midwifery Today Int Midwife 71 (2004) 9-12
5. Garris R.E., and Kirkwood C.F. Misoprostol: a prostaglandin E1 analogue. Clin Pharm Sep 8 9 (1989) 627-644
6. Walt R.P. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N Engl J Med Nov 26 327 22 (1992) 1575-1580
7. Barradell L.B., Whittington R., and Benfield P. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs. Pharmacoeconomics 3 2 (Feb 1993) 140-171
8. Barbosa R.M., and Arilha M. The Brazilian experience with Cytotec. Stud Fam Plann 24 4 (1993) 236-240
9. Costa S.H., and Vessey M.P. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet May 15 341 8855 (1993) 1258-1261
10. Miller S., Lehman T., Campbell M., Hemmerling A., Anderson S.B., Rodriguez H., et al. Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republics: a temporal association. BJOG 112 (2005) 1291-1296
11. Mariani Neto C., Leão E.J., Barreto M.C.P., Kenj G., Aquino M.M., and Tuffi V.H.B. Uso do misoprostol para indução do parto com feto morto. Rev Paul Med 105 (1987) 305-308
12. Bugalho A., Bique C., Machungo F., and Faundes A. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol 171 2 (Aug 1994) 538-541
13. Margulies M., Campos Perez G., and Voto L.S. Misoprostol to induce labor [letter]. Lancet 339 (1992) 364
14. Grimes D.A. Mifepristone (RU 486) for induced abortion. Womens Health Issues 3 3 (1993) 171-175
15. Bugalho A., Bique C., Machungo F., and Faundes A. Low-dose vaginal misoprostol for induction of labor with a live fetus. Int J Gynecol Obstet 49 2 (May 1995) 149-155
16. Reichler A., Romem Y., and Divon M.Y. Induction of labor. Curr Opin Obstet Gynecol 7 6 (Dec 1995) 432-436
17. Bauer T., Brown D., and Chai L. Vaginal misoprostol for term labor induction. Ann Pharmacother 31 (1997) 1391-1393
18. el Refaey H., and Jauniaux E. Methods of induction of labour. Curr Opin Obstet Gynecol 9 6 (Dec 1997) 375-378
19. Bugalho A., Bique C., Almeida L., and Faúndes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 24 5 (1993) 319-323
20. Murray S., and Muse K. Mifepristone and first trimester abortion. Clin Obstet Gynecol Jun 39 2 (1996) 474-485
21. Scheepers H.C., van Erp E.J., and van den Bergh A.S. Use of misoprostol in first and second trimester abortion: a review. Obstet Gynecol Surv Sep 54 9 (1999) 592-600
22. Christin-Maitre S., Bouchard P., and Spitz I.M. Medical termination of pregnancy. N Engl J Med Mar 30 342 13 (2000) 946-956
23. Has R., Batukan C., Ermis H., Cevher E., Araman A., Kilic G., et al. Comparison of 25 and 50 ug vaginally administered misoprostol for preinduction cervical ripening and labor induction. Gynecol Obstet Invest 53 (2002) 16-21
24. Perry K.G., Larmon J.E., May W.L., Robinette L.G., and Martin R.W. Cervical ripening: a randomized comparison between intravaginal misoprostol and an intracervical balloon catheter combined with intravaginal dinoprostone. Am J Obstet Gynecol 178 (1998) 1333-1340
25. Wing D.A., Ham D., and Paul R.H. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. Am J Obstet Gynecol 180 (1999) 1155-1159
26. Diro M., Adra A., Gilles J.M., Nassar A., Rodriguz A., Salamat S., et al. A double-blind randomized trial of two dose regimen of misoprostol for cervical ripening and labor induction. J Matern Fetal Med 8 (1999) 114-118
27. Alfirevic Z., and Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev Issue 2 (2006) Art. No.: CD001338, doi:10.1002/14651858.CD001338.pub2.
28. Golberg A.B., Greenberg M.B., and Darney P.D. Misoprostol and pregnancy. N Engl J Med 344 (2001) 38-47
29. Neilson J.P., Hickey M., and Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database Syst Rev Issue 3 (2006) Art. No.:CD002253. doi:10.1002/14651858.CD002253.pub3.
30. Clark W., Shannon C., and Winikoff B. Misoprostol for uterine evacuation in induced abortion and pregnancy failure. Expert Rev Obstet Gynecol 2 1 (2007) 67-108
31. Derman R.J., Kodkany B.S., Goudar S.S., et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet 368 (2006) 1248-1253
32. Hoj L., Cardosa P., Nielsen B.B., Hvidman L., Nielsen J., and Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial. BMJ 331 (2005) 723
33. Briozzo L., Vidiella G., Rodriguez F., Gorgoroso M., Faúndes A., and Pons J.E. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion. Int J Gynecol Obstet 95 2 (Nov 2006) 221-226
34. Faúndes A., Santos L.C., Carvalho M., and Gras C. Post-abortion complications after interruption of pregnancy with misoprostol. Adv Contracep 12 1 (1996) 1-9
35. Viggiano M., Faúndes A., Borges A.L., Viggiano A.B.F., Souza G.R., and Rabello I. Disponibilidade de misoprostol e complicações de aborto provocado em Goiana. J Bras Ginecol 106 3 (1996) 55-61
36. American College of Obstetricians and Gynecologists. New US Food and Drug Administration Labelling on Cytotec (misoprostol) Use and Pregnancy. ACOG Comm Opin vol. 283 (2003) Washington DC.
37. World Health Organization. 15th WHO Model List of Essential Medicines (March 2007), World Health Organization, Geneva
38. Weeks A.D., Fiala C., and Safar P. Misoprostol and the debate over off-label drug use. BJOG: Int J Obstet Gynaecol 112 (2005) 269-272
39. McManus A., Herring C., and Weeks A. What proportion of antenatal prescriptions are licensed at Liverpool Women's' Hospital?. Data presented at British International Congress of Obstetrics and Gynaecology (July 2007)
40. USFDA. "Off-label" and Investigational Use of Marketed Drugs, Biologics and Medical Devices. Guidance for Institutional Review Boards and Clinical Investigators: 1998 Update. Available from: www.fda.gov/oc/ohrt/irbs/offlabel.html. Accessed on January 31, 2005
41. In: Faundes A. (Ed). Uso De Misoprostol En Obstetricia Y Ginecologia. Federacion Latinoamericana De Sociedades De Obstetricia Y Ginecologia (FLASOG) (2005)
42. Abdel-Aleem H. Misoprostol for labour induction. Reproductive Health Library commentary vol. 7 (2004), Reproductive Health Library, WHO, Oxford